New work by Columbia researchers has turned a textbook principle of genetics on its head and revealed why some people who carry disease-causing genes experience no symptoms.
After multiple clinical trial failures, FibroGen lays off one-third of staff
FibroGen is laying off 104 employees in the US, it disclosed in an SEC filing Wednesday morning. That equates to 32% of its workforce, the